SAN FRANCISCO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Lockheed Martin Corporation (NYSE: LMT) on behalf of investors who purchased shares between January 23, 2024, and July 21, 2025. The lawsuit, captioned Khan v. Lockheed Martin Corporation, alleges that the company misled investors about the financial health and performance of its Aeronautics and Rotary and Mission Systems (RMS) business segments. Hagens Berman encourages Lockheed Martin investors with s ...

Core Points - The High Court ruled that Hewlett Packard (HP) is owed nearly $1 billion by the estate of the late Mike Lynch and his former business partner due to HP's acquisition of Autonomy [1][2] - HP is entitled to $944 million for the difference between the price paid for Autonomy and what it would have paid had it known the company's true financial position, along with an additional $47.5 million for losses related to hardware sales and other transactions [2] Legal Background - HP sued Lynch and Hussain in 2015, alleging they orchestrated a fraud to inflate Autonomy's value, which HP acquired for $11.1 billion in 2011 [4][5] - The deal fell apart within a year, leading HP to write down Autonomy's value by $8.8 billion and file a $5 billion lawsuit against Lynch and Hussain [4][8] Court Rulings - The High Court previously ruled in HP's favor in 2022, indicating that HP would receive "considerably less" than the initially claimed $5 billion [6] - Judge Robert Hildyard determined that HP would have paid £23 per share instead of the £25.50 actually paid for Autonomy, stating that HP's claim was "substantially exaggerated" [8] Future Proceedings - A further hearing is scheduled for November to address any applications for permission to appeal and the division of damages between Lynch's estate and Hussain, who has already settled with HP [3]

Core Viewpoint - Petco Health and Wellness Company, Inc. is facing allegations regarding the sustainability of its business model and the accuracy of its public statements, particularly related to its pandemic-related growth and product strategy [2]. Group 1: Allegations - The pandemic-related growth experienced by Petco is claimed to be unsustainable, as is its focus on premium and high-grade pet food [2]. - The strength of Petco's differentiated product strategy is alleged to have been overstated [2]. - Defendants are accused of downplaying the severity of issues affecting the company and the necessary changes to address these issues [2]. - There are claims that Petco's ability to achieve sustainable and profitable growth was overstated [2]. - Public statements made by the defendants are described as materially false and misleading throughout the relevant period [2]. Group 2: Class Action Details - The class period for the allegations spans from January 14, 2021, to June 5, 2025 [2]. - Shareholders are encouraged to register for the class action by the deadline of August 29, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - A securities class action lawsuit has been filed against Reckitt Benckiser Group PLC for failing to disclose material information during the Class Period, which may have led to economic losses for investors [3][4]. Group 1: Lawsuit Details - Investors who purchased Reckitt's American Depositary Shares (ADSs) between January 13, 2021, and July 28, 2024, have until August 4, 2025, to file lead plaintiff applications [1][2]. - The lawsuit alleges that Reckitt and certain executives violated federal securities laws by not disclosing risks associated with their cow's milk-based formula, Enfamil, which could lead to increased legal claims and impact sales [3][4]. Group 2: Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing the plaintiffs in this case [5]. - The firm has a strong track record, being ranked among the top 10 firms nationally based on total settlement value [5].

Core Viewpoint - Petco Health and Wellness Company, Inc. is facing allegations regarding the sustainability of its business model and the accuracy of its public statements, particularly related to its pandemic-driven growth and product strategy [2]. Group 1: Allegations and Class Action Details - The class period for the allegations against Petco spans from January 14, 2021, to June 5, 2025 [2]. - Allegations include that Petco's pandemic-related growth was unsustainable and that its premium pet food business model was overstated [2]. - Defendants are accused of downplaying the severity of issues affecting the company and overstating its ability to achieve sustainable, profitable growth [2]. Group 2: Shareholder Actions - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by the deadline of August 29, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. - Participation in the case does not incur any costs or obligations for the shareholders [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [4].

Core Viewpoint - UnitedHealth Group is under criminal investigation for fraud and has suspended its fiscal guidance for 2025, leading to significant stock price decline and potential legal claims from investors [1][2]. Group 1: Legal Investigations - UnitedHealth is facing a criminal investigation by the U.S. Department of Justice (DOJ) related to its Medicare Advantage program [2]. - The company is also subject to a civil investigation by the DOJ concerning its Medicare billing practices [2]. - An antitrust investigation is ongoing regarding UnitedHealth's Optum health services division [2]. - A class action lawsuit has been filed against UnitedHealth in the U.S. District Court for the District of Minnesota [2][3]. Group 2: Management Changes - CEO Andrew Witty resigned on May 13, 2025, citing "personal reasons," coinciding with the suspension of the company's fiscal guidance for 2025 [2]. Group 3: Financial Impact - UnitedHealth's stock price has decreased by approximately 50% since April 2025 due to the revelations of the investigations, resulting in substantial losses for shareholders [2].

Core Viewpoint - Abacus Global Management is facing significant pressure as its stock price has dropped over 36% in the past month due to serious allegations from Morpheus Research regarding financial misconduct and questionable accounting practices [1][5]. Group 1: Allegations and Investigations - Morpheus Research, a new investigative group with ties to Hindenburg Research, published reports accusing Abacus of manipulating its life settlements portfolio through aggressive accounting practices, leading to inflated asset values and "fake revenue" [3][4]. - Hagens Berman, a prominent law firm, has initiated its own investigation into the claims made by Morpheus Research, urging affected shareholders to report their financial losses [2][6]. - The scrutiny intensified after Morpheus's follow-up report alleged inconsistencies in Abacus's rebuttal and introduced claims of undisclosed related-party transactions [4]. Group 2: Company Response and Stock Performance - In response to the allegations, Abacus retained independent actuarial firm Lewis & Ellis to review its balance sheet and reassure investors of compliance with accounting standards [4]. - Despite the company's efforts, including a $20 million share repurchase program aimed at restoring investor confidence, the stock has continued to trade near its 52-week low [5][6]. - The stock experienced a sharp 20% drop in a single day following the initial report from Morpheus [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Organon & Co. regarding a class action lawsuit due to allegations of misleading statements and concealment of material facts related to the company's capital allocation and dividend strategy [1][2]. Allegations - The complaint alleges that Organon's management provided overly positive statements while concealing the prioritization of debt reduction following the acquisition of Dermavant, which led to a significant reduction in the quarterly dividend by 70% [1]. - Following the announcement of the dividend cut, Organon's stock price plummeted from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, marking a decline of over 27% in just one day [1]. Class Action Details - Shareholders who purchased shares during the class period from October 31, 2024, to April 30, 2025, are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for July 22, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case, with no cost or obligation to participate [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices, aiming to ensure companies adhere to responsible business practices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Strategy Incorporated (NASDAQ: MSTR) regarding a class action lawsuit related to misleading statements about the company's bitcoin investment strategy and treasury operations [1][3]. Group 1: Allegations - The complaint alleges that during the class period from April 30, 2024, to April 4, 2025, the defendants made materially false and misleading statements [3]. - It is claimed that the anticipated profitability of the company's bitcoin-focused investment strategy was overstated [3]. - The risks associated with bitcoin's volatility and potential losses from digital assets were understated, leading to misleading public statements [3]. Group 2: Class Action Details - Shareholders who purchased MSTR shares during the specified class period are encouraged to register for the class action, with a deadline of July 15, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of UnitedHealth Group Incorporated regarding a class action lawsuit alleging that the company engaged in misleading practices that harmed investors [1][2]. Allegations - The complaint claims that UnitedHealth had a corporate strategy of denying health coverage to increase profits and share price [1]. - This strategy led to regulatory scrutiny and public outrage, culminating in the murder of Brian Thompson, which further damaged the company's reputation [1]. - Following the incident, there was significant public animosity towards UnitedHealth, with many Americans expressing support for the accused killer and demanding changes in the company's practices [1]. - Despite the backlash, UnitedHealth continued to provide unrealistic guidance the day before Thompson's murder, which was inconsistent with its changing corporate strategies [1]. - The allegations assert that the defendants' public statements were materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from December 3, 2024, to April 16, 2025, with a deadline for shareholders to register as lead plaintiffs by July 7, 2025 [2]. - Shareholders who register will receive updates on the case through portfolio monitoring software [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and illegal business practices, ensuring companies adhere to responsible business conduct [3].